LXRX
Price
$1.82
Change
-$0.00 (-0.00%)
Updated
Oct 2 closing price
Capitalization
845.42M
40 days until earnings call
Intraday BUY SELL Signals
VKTX
Price
$29.94
Change
-$0.57 (-1.87%)
Updated
Oct 2 closing price
Capitalization
4.11B
26 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LXRX vs VKTX

LXRX vs VKTX Comparison Chart in %
View a ticker or compare two or three
VS
LXRX vs. VKTX commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LXRX is a StrongBuy and VKTX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
LXRX vs VKTX: Fundamental Ratings
LXRX
VKTX
OUTLOOK RATING
1..100
9183
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
52
Fair valued
PROFIT vs RISK RATING
1..100
10078
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
5755
P/E GROWTH RATING
1..100
16100
SEASONALITY SCORE
1..100
15n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VKTX's Valuation (52) in the Biotechnology industry is in the same range as LXRX (71). This means that VKTX’s stock grew similarly to LXRX’s over the last 12 months.

VKTX's Profit vs Risk Rating (78) in the Biotechnology industry is in the same range as LXRX (100). This means that VKTX’s stock grew similarly to LXRX’s over the last 12 months.

LXRX's SMR Rating (97) in the Biotechnology industry is in the same range as VKTX (98). This means that LXRX’s stock grew similarly to VKTX’s over the last 12 months.

VKTX's Price Growth Rating (55) in the Biotechnology industry is in the same range as LXRX (57). This means that VKTX’s stock grew similarly to LXRX’s over the last 12 months.

LXRX's P/E Growth Rating (16) in the Biotechnology industry is significantly better than the same rating for VKTX (100). This means that LXRX’s stock grew significantly faster than VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LXRXVKTX
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 15 days ago
86%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (LXRX: $1.82 vs. VKTX: $30.51)
Brand notoriety: LXRX and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LXRX: 77% vs. VKTX: 174%
Market capitalization -- LXRX: $845.42M vs. VKTX: $4.11B
LXRX [@Biotechnology] is valued at $845.42M. VKTX’s [@Biotechnology] market capitalization is $4.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LXRX’s FA Score shows that 1 FA rating(s) are green while VKTX’s FA Score has 0 green FA rating(s).

  • LXRX’s FA Score: 1 green, 4 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, LXRX is a better buy in the long-term than VKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LXRX’s TA Score shows that 4 TA indicator(s) are bullish while VKTX’s TA Score has 4 bullish TA indicator(s).

  • LXRX’s TA Score: 4 bullish, 6 bearish.
  • VKTX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both LXRX and VKTX are a bad buy in the short-term.

Price Growth

LXRX (@Biotechnology) experienced а -2.15% price change this week, while VKTX (@Biotechnology) price change was -16.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

LXRX is expected to report earnings on Nov 11, 2026.

VKTX is expected to report earnings on Oct 28, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
LXRX
Daily Signal:
Gain/Loss:
VKTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WSM233.395.45
+2.39%
Williams-Sonoma
ARIS17.32-0.08
-0.46%
Aris Mining Corp.
CTKB5.81-0.15
-2.52%
Cytek Biosciences
XCUR1.12-0.03
-2.61%
Exicure Inc
GRO2.11-0.10
-4.52%
Brazil Potash Corp

LXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXRX has been loosely correlated with PLRX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if LXRX jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXRX
1D Price
Change %
LXRX100%
-2.93%
PLRX - LXRX
58%
Loosely correlated
-2.78%
CRBU - LXRX
39%
Loosely correlated
-3.94%
IMNM - LXRX
38%
Loosely correlated
-2.88%
VKTX - LXRX
37%
Loosely correlated
-6.41%
VCYT - LXRX
37%
Loosely correlated
-4.02%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with EDIT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
-6.41%
EDIT - VKTX
50%
Loosely correlated
-1.95%
KURA - VKTX
49%
Loosely correlated
-0.56%
BEAM - VKTX
46%
Loosely correlated
-0.25%
JAGX - VKTX
46%
Loosely correlated
-12.22%
IMNM - VKTX
45%
Loosely correlated
-2.88%
More